One other factor that could potentially impact the transcriptional activity of JDP2 is that approximately half of ETP-ALL cases have inactivating mutations of members of the PRC2 complex (Zhang et al., 2012). The gene discussed is JDP2; the disease is acute lymphoblastic leukemia.